Invista 70 mg Tablet
11,05$
9,07$
Invista 70 mg Tablet is an innovative anti-cancer medication that utilizes dasatinib as its active ingredient, specifically designed to combat certain malignancies. This potent tablet is primarily indicated for the treatment of chronic myeloid leukemia (CML), a serious blood cancer characterized by the overproduction of abnormal white blood cells. Dasatinib works by inhibiting specific proteins that drive the growth of cancer cells, thereby helping to restore normal cell function. While Invista can be effective in managing CML, it is essential for patients to be aware of potential side effects, such as bleeding, infections, or heart issues, which may arise during treatment. Regular monitoring by healthcare professionals is crucial to ensure optimal safety and effectiveness. Patients should inform their doctors about any existing medical conditions or medications they are taking, as these factors can influence treatment outcomes. With its targeted action and clinical efficacy, Invista 70 mg Tablet plays a vital role in advancing cancer care and improving the quality of life for those affected by chronic myeloid leukemia.
Quantité
Active Pharmaceutical Ingredient
Uses
• Invista 70 mg tablet is primarily utilized in the treatment of chronic myeloid leukemia (CML). This condition impacts the blood and bone marrow, leading to various symptoms such as fatigue and weakness. By targeting the underlying mechanisms of CML, Invista 70 mg tablet helps manage the disease and improve patients' quality of life. This medication is essential for individuals diagnosed with this specific type of leukemia.
• Another significant application of Invista 70 mg tablet is in the management of acute lymphoblastic leukemia (ALL). ALL is a rapidly progressing cancer that originates in the bone marrow, affecting white blood cells. Patients may experience symptoms like shortness of breath and easy bruising. The use of Invista 70 mg tablet in this context aims to control the proliferation of cancerous cells and support the patient's overall health.
• In treating both CML and ALL, Invista 70 mg tablet serves as a crucial part of a comprehensive therapeutic strategy. It is often prescribed alongside other medications to enhance treatment efficacy. The targeted action of Invista 70 mg tablet helps to address the specific challenges posed by these leukemias. Healthcare providers frequently recommend this medication for patients facing these conditions.
• Invista 70 mg tablet is an important option for patients undergoing treatment for leukemia, particularly CML and ALL. Its role in managing these cancers can significantly impact treatment outcomes. By incorporating Invista 70 mg tablet into their regimen, patients may experience better control over their symptoms and disease progression. This medication is a valuable component in the fight against these forms of leukemia.
Benefits
Invista 70 mg Tablet is effective and has a high rate of response in people with chronic myeloid leukemia (CML) and acute lymphoblastic leukemia. It decreases the number of cancer cells in the blood and bone marrow and improves blood counts in people with CML or ALL. Invista Tablet is usually taken once a day, which may be more convenient for some people compared to other treatments. Anti-cancer Drug Invista is effective in people with CML or ALL who have not responded to other treatments.
Side Effects
Invista 70 mg Tablet may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Fever
• Nausea
• Vomiting
• Bleeding
• Skin rash
• Diarrhoea
• Infection
• Bone marrow suppression
• Pleural effusion
• Abdominal pain
Common Side Effects
• Difficulty breathing
• Headache
• Tiredness
• Fatigue
• Muscle and joint pain
• Swelling in the hands and feet
How To Use
Invista 70 mg Pack may be taken with or without food. Take it at the same time each day. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Dasatinib Tablet 70 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Dasatinib Tablet 70 mg and report any unusual symptoms or changes in kidney function to their physician. The dose of Anti-cancer Drug Invista should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Invista 70 mg. Invista 70 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Dasatinib Tablet 70 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Dasatinib Tablet 70 mg should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Invista 70 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Invista 70 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Invista Tablet may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Invista 70 mg Pack during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Invista 70 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Invista 70 mg.